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Abstract	1	 We	 show	 here	 that	 quiescent	 (Q-Cell)	 Escherichia	 coli	 cultures	 can	 maintain	 metabolic	2	 activity	 in	 the	 absence	 of	 growth	 for	 up	 to	 24	 h,	 leading	 to	 four	 times	 greater	 specific	3	 productivity	of	a	model	metabolite,	3-hydroxybutyrate	(3HB),	than	a	control.	Q-cells	can	be	4	 created	by	using	the	proton	ionophore	indole	to	halt	cell	division	of	an	hns	mutant	strain.	5	 This	uncouples	metabolism	from	cell	growth	and	allows	for	more	efficient	use	of	carbon	6	 feedstocks	 because	 less	 metabolic	 effort	 is	 diverted	 to	 surplus	 biomass	 production.	7	 However,	 the	 reason	 for	 the	 increased	 productivity	 of	 cells	 in	 the	 quiescent	 state	 was	8	 previously	unknown.	In	this	study,	proteome	expression	patterns	between	wild-type	and	9	 Q-cell	cultures	show	that	Q-cells	overexpress	stress	response	proteins,	which	prime	them	10	 to	tolerate	the	metabolic	imbalances	incurred	through	indole	addition.	Metabolomic	data	11	 reveal	the	accumulation	of	acetyl-coenzyme	A	and	phosphoenolpyruvate:	excellent	starting	12	 points	 for	 high-value	 chemical	 production.	 We	 demonstrated	 the	 exploitation	 of	 these	13	 accumulated	metabolites	by	engineering	a	simple	pathway	for	3HB	production	from	acetyl-14	 coenzyme	A.	Quiescent	cultures	produced	half	the	cell	biomass	of	control	cultures	lacking	15	 indole,	but	were	still	able	to	produce	39.4	g	L-1	of	3HB	compared	to	18.6	g	L-1	in	the	control.	16	 Q-cells	therefore	have	great	potential	as	a	platform	technology	for	the	efficient	production	17	 of	a	wide	range	of	commodity	and	high	value	chemicals.	18	 	 	19	
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1	Introduction	1	 The	bacterium	Escherichia	coli	offers	abundant	opportunities	for	use	as	a	cell	factory	for	2	 the	commercial	scale	production	of	high	value	or	commodity	chemicals	from	cheap,	3	 renewable	feedstocks	[1–4].	In	E.	coli	and	other	microbes,	carbon	flux	through	the	central	4	 carbon	metabolism	pathways	of	glycolysis,	the	pentose	phosphate	pathway	(PPP)	and	the	5	 tricarboxylic	acid	cycle	(TCA)	is	at	a	maximum	during	exponential	growth	[5].	6	 Consequently,	microbe-based	bioproduction	processes	usually	aim	to	extend	the	7	 exponential	phase	for	as	long	as	possible	before	nutrient	limitation,	oxygen	deprivation	or	8	 the	accumulation	of	toxic	by-products	inhibit	further	carbon	metabolism	and	cell	growth	9	 [6–8].	Consequentially,	large	amounts	of	biomass	are	generated	by	this	strategy.	To	10	 generate	biomass	requires	the	diversion	of	chemical	feedstocks	for	maintenance	of	cell	11	 function	and	production	of	essential	macromolecules	[9],	thereby	reducing	the	yield	of	the	12	 intended	product.	High	cell	density	batch	production	also	poses	significant	engineering	13	 challenges	to	increase	nutrient	and	oxygen	uptake	rates,	provide	sufficient	mixing	and	14	 cooling,	and	to	separate	product	efficiently	from	the	accumulated	biomass.	15	 	16	 Continuous	production	using	a	chemostat	solves	some	of	these	problems	by	removing	17	 cells	at	the	same	rate	as	they	are	produced	by	division	[10,	11].	In	some	situations	it	is	also	18	 possible	to	use	‘resting	cells’	in	an	osmotically-balanced	but	nutrient-limited	buffer	such	19	 as	phosphate	buffered	saline	[12,	13].	However,	these	approaches	are	technically	more	20	 challenging	and	suffer	from	problems	including	vulnerability	to	contamination	in	21	 chemostats	and	limited	viable	lifespans	of	resting	cells.	22	 	23	 The	non-growing	but	metabolically	active	quiescent	cell	expression	system	(Q-cells)	24	 diverts	resources	away	from	unwanted	biomass	accumulation	and	towards	product	25	 formation	[14].	Quiescence	is	achieved	by	addition	of	2.5	–	3.0	mM	indole	to	cultures	of	E.	26	
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coli	W3110	carrying	a	stop	codon	after	the	93rd	codon	of	the	hns	gene	(hnsΔ93).	This	1	 mutation	causes	the	production	of	a	truncated	Histone-like	Nucleoid	Structuring	protein	2	 (H-NS).	After	indole	is	added,	metabolic	activity	continues	and	production	of	plasmid-3	 encoded	proteins	is	increased,	but	only	in	hns	mutants	[15,	16].	Indole	is	a	well-studied	4	 chemical	signal	in	over	85	species	of	bacteria	[17].	It	is	a	proton	ionophore	and	has	been	5	 shown	to	reduce	the	proton-motive	force	(PMF)	of	E.	coli	by	allowing	protons	to	return	to	6	 the	cytoplasm	after	their	expulsion	to	the	periplasmic	space	during	oxidative	7	 phosphorylation	[18].	One	effect	of	reducing	the	PMF	is	to	prevent	the	formation	of	the	8	 FtsZ	ring,	which	is	a	prerequisite	for	cell	division.	Therefore,	at	suitable	concentrations	9	 indole	is	able	to	prevent	E.	coli	cell	division	[19].	10	 	11	 Q-cells	have	previously	only	been	investigated	for	the	production	of	proteins	[16].	Here,	we	12	 demonstrate	 the	 potential	 for	 using	 Q-cells	 to	 synthesise	 a	 wide	 and	 diverse	 range	 of	13	 industrially-relevant	small	molecules	under	fed-batch	conditions.	Using	metabolomic	and	14	 proteomic	 approaches,	 we	 move	 towards	 a	 greater	 understanding	 of	 the	 mechanisms	15	 underlying	 the	 quiescent	 state.	 We	 also	 show	 that	 quiescent	 cells	 accumulate	 a	 large	16	 reservoir	of	acetyl-coenzymeA	(Ac-CoA).	To	demonstrate	the	tractability	of	the	system,	we	17	 designed	a	 simple	 fermentation	 strategy	 for	 improved	production	of	 3-hydroxybutyrate	18	 (3HB)	from	Ac-CoA.	19	 	20	
2	Materials	and	methods	21	
2.1	Strains	and	growth	conditions.	The	wild-type	strain	used	as	the	control	was	E.	coli	22	 W3110	(ATCC	27325).	To	create	the	Q-cell	strain,	the	hnsΔ93	mutation	was	introduced	to	23	 the	wild-type	strain	using	the	lambda	Red	recombinase	system,	as	described	previously	24	 [15].	Strains	were	stored	with	glycerol	at	-80	°C	and	streaked	onto	Luria-Bertani	(LB)	agar	25	 plates	before	use.	A	5	ml	starter	culture	was	then	grown	in	LB	liquid	medium	for	8	h	at	37	26	
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°C	and	used	to	inoculate	further	cultures	for	the	experiments.	The	hnsΔ93	mutation	1	 confers	kanamycin	resistance	to	the	Q-cell	strain.	For	selection	purposes,	Q-cell	plates	and	2	 starter	cultures	contained	kanamycin	(30	μg	mL-1).	However,	to	keep	the	conditions	used	3	 for	each	strain	as	similar	as	possible,	no	antibiotics	were	used	for	experimental	cultures,	4	 except	when	necessary	for	maintenance	of	the	3HB	production	plasmid.	5	
	6	 For	the	metabolome	and	proteome	studies,	cultures	were	grown	in	M9	medium	(12.8	g	L-1	7	 Na2HPO4.7H2O,	3	g	L-1	KH2PO4,	0.5	g	L-1	NaCl,	1	g	L-1	NH4Cl	and	0.24	g	L-1	MgSO4)	8	 supplemented	with	4	g	L-1	glucose,	2	g	L-1	yeast	extract	and	1	ml.L-1	of	a	trace	elements	9	 solution	(9.7	g	L-1	FeCl3,	7.8	g	L-1	CaCl2,	0.218	g	L-1	CoCl2.6H2O,	0.156	g	L-1	CuSO4.5H2O,	10	 0.118	g	L-1	NiCl3.6H2O	and	0.105	g	L-1	CrCl3.6H2O	dissolved	in	0.1	M	HCl).	Seed	cultures	11	 (300	mL)	were	inoculated	with	3	mL	of	LB	starter	culture	in	1	L	baffled	Erlenmeyer	flasks	12	 and	grown	for	16	h	overnight	with	shaking	at	300	rpm.	13	 	14	 Following	inoculation	of	the	fermentor	(final	volume	of	3	L	in	a	10	L	vessel),	cultures	were	15	 grown	in	batch	mode	until	the	glucose	supply	was	exhausted,	indicated	by	a	rise	in	16	 dissolved	oxygen	(DO)	and	pH,	and	confirmed	by	testing	with	a	hand-held	FreeStyle	17	 Optium	glucose	meter	(Abbott	Laboratories,	UK).	Feed	solution	(180	g	L-1	glucose,	22	g	L-1	18	 NH4Cl,	5.42	g	L-1	MgSO4)	was	then	introduced	at	1.5	mL	min-1	by	peristaltic	pump.	19	 Throughout	the	experiment,	the	temperature	was	controlled	at	37	°C,	agitation	speed	was	20	 a	constant	500	rpm	(sufficient	to	maintain	DO	above	40	%)	and	pH	was	maintained	at	7.0	21	 by	addition	of	5	M	NaOH	as	necessary.	Control	of	foaming	was	only	necessary	for	wild-22	 type	cultures	without	indole,	and	was	achieved	by	automatic	addition	of	antifoam	agent	A	23	 (Sigma-Aldrich,	US)	controlled	by	a	foam	level	probe.	24	 	25	
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After	a	30	min	equilibration	period,	indole	dissolved	in	ethanol	(1	M)	was	added	in	a	1	 single	shot	to	a	final	concentration	of	3	mM.	An	equivalent	volume	of	pure	ethanol	was	2	 added	for	no-indole	controls.	The	growth	of	each	culture	was	monitored	by	measuring	the	3	 optical	density	at	600	nm	(OD600)	of	samples.	Although	the	growth	rates	differed	between	4	 strains,	the	OD600	at	the	start	of	the	feeding	stage	was	the	same	for	all	cultures.		5	 	6	 For	the	production	of	3HB,	a	similar	strategy	was	followed	to	that	described	above.	7	 However,	a	complex	medium	could	be	used	as	it	was	no	longer	necessary	to	avoid	8	 activating	alternative	metabolic	pathways,	as	in	the	metabolome	study.	This	also	allowed	9	 both	strains	to	grow	at	equal	rates.	We	used	terrific	broth	(TB)	at	all	stages	of	the	3HB	10	 production	experiments.	TB	medium	consists	of	24	g	L-1	yeast	extract,	12	g	L-1	peptone,	9.4	11	 g	L-1	K2HPO4,	2.2	g	L-1	KH2PO4,	4	g	L-1	glucose	and	2.4	g	L-1	MgSO4.	A	100	mL	pre-culture	of	12	
E.	coli	W3110hnsΔ93/pTrctesBphaAB	was	grown	overnight	in	TB	medium	at	37	°C	then	13	 used	to	inoculate	the	fermentor	(5	L	vessel),	which	contained	a	further	1.9	L	of	fresh	TB	14	 medium.	Ampicillin	(100	μg/mL)	was	included	in	all	growth	media	and	the	nutrient	feed,	15	 to	select	for	cells	containing	the	plasmid.		16	 	17	 When	the	original	glucose	supply	was	depleted	(signaled	by	a	rise	in	pH),	a	feed	medium	18	 consisting	of	190	g	L-1	glucose,	108	g	L-1	peptone,	84	g	L-1	yeast	extract,	9.4	g	L-1	K2HPO4,	19	 2.2	g	L-1	KH2PO4	and	1.2	g	L-1	MgSO4	was	pumped	into	the	fermentor	at	an	initial	flow	rate	20	 of	0.28	mL	min-1.	The	ratio	of	glucose	to	complex	nitrogen	in	this	feed	was	kept	much	21	 higher	than	TB	medium	to	provide	a	better	stoichiometric	balance.	The	flow	rate	was	22	 increased	exponentially	so	as	to	double	every	2	h	pre-induction	to	keep	pace	with	the	23	 growth	rate	of	the	cells.	Indole	was	dissolved	in	ethanol	to	150	mM	and	pumped	into	the	24	 fermentor	at	a	rate	of	0.28	mL	min-1	for	2	h,	through	a	tube	that	exited	below	the	level	of	25	 the	medium	to	ensure	good	dissolution.	Induction	was	done	with	IPTG	(1	mM	final	26	
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concentration)	30	min	after	the	start	of	the	indole	feed.	The	feed	rate	post	induction	was	1	 kept	constant	since	we	observed	a	drop	in	the	growth	rate	of	the	cells.	2	 	3	 Cell	growth	was	measured	as	OD600	following	appropriate	dilution	and	as	cell	dry	weight	4	 (CDW)	by	collecting	the	cells	from	two	1	mL	samples	through	centrifugation	and	drying	in	5	 an	oven	until	constant	weight.	The	average	of	the	two	weights	was	reported.	Glucose	6	 concentrations	were	recorded	using	a	medical	glucose	meter	and	disposable	enzyme	assay	7	 strips.	Substrate	consumption	rates	(with	respect	to	glucose)	were	calculated	from	a	8	 material	balance	on	the	amount	fed	per	unit	time	and	the	residual	glucose	concentration	9	 in	the	culture	medium.	Following	centrifugation	at	17,000	×	g	for	2	minutes	to	remove	the	10	 cells,	samples	of	the	supernatant	(1	mL)	were	kept	at	-80	°C	before	testing	for	3HB	11	 concentrations	using	a	β-hydroxybutyrate	colorimetric	assay	kit	(Cayman	Chemicals,	US).		12	 	13	
2.2	3-hydroxybutyrate	production	plasmid	construction.	Plasmid	pTrctesBphaAB	was	14	 constructed	from	plasmid	pTrcphaCABRe	which	was	generously	provided	by	Dr.	Takeharu	15	 Tsuge	(Tokyo	Institute	of	Technology,	Japan)	[20],	by	replacing	the	phaC	gene	with	tesB.	16	 The	artificial	operon	thus	created	encoded	for	a	3-enzyme	pathway	in	which	3-17	 hydroxybutyryl-CoA	is	produced	from	Ac-CoA	by	PhaA	and	PhaB,	and	the	CoA	moiety	is	18	 then	removed	by	TesB	to	leave	3-HB.	The	tesB	gene	was	amplified	by	PCR	from	plasmid	19	 pCA24N:TesB	[21]	and	the	product	was	purified	using	a	QIAQuick	PCR	purification	20	 column	(Qiagen,	USA).	Plasmid	pTrcphaCABRe	was	linearised	by	digestion	with	EcoRI	and	21	 SalI	and	the	plasmid	backbone	was	then	ligated	with	the	tesB	fragment	by	Gibson	22	 Assembly	according	to	the	manufacturer’s	instructions	of	a	kit	provided	by	New	England	23	 Biolabs	(US).	The	primers	used	for	Gibson	Assembly	were:	24	 	25	 Forward:	5’-AACAATTTCACACAGGAAACAGACCATGGAATTCAGATCTTTCG	26	
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AATAGTGACGGCAGAGAGACAATCAAATCATG-3’	1	 	2	 Reverse:	5’-CAAAACAGCCAAGCTTGCATGCCTGCAGGTCGACTCTAGAGGAT	3	 CCAAACCCGGTGAATTGGCGCA-3’	4	 	5	
2.3	Time-course	study	of	metabolomics	changes.	Samples	were	taken	immediately	6	 before	indole	addition	and	at	six	other	points	over	the	next	4	hours	(5,	15,	30,	60,	120	and	7	 240	min	after	indole	addition).	Approximately	20	mL	samples	were	drawn	aseptically	8	 from	the	fermentor,	1	mL	aliquots	of	which	were	used	for	the	metabolomics	study.	The	9	 OD600	of	each	sample	was	measured	with	appropriate	dilution	and	recorded,	and	later	10	 used	to	normalise	the	metabolite	concentrations.	We	obtained	samples	for	metabolite	11	 quantification	by	vacuum	filtering	1	mL	of	each	culture	and	quenching	the	cells	by	12	 immersion	in	cold	(-80	°C)	methanol	within	30	sec	of	withdrawal.	The	samples	were	13	 stored	in	methanol	at	-80	°C	until	preparation	for	analysis.	14	 	15	
2.4	LC-MS/MS	analysis	of	metabolites.	Prior	to	analysis,	metabolites	were	extracted	16	 using	a	previously	described	method	with	modifications	[22,	23].	Briefly,	the	metabolites	17	 were	extracted	into	a	1.2 ml	solvent	mixture	(CHCl3:H2O,	1:1,	v/v)	containing	10 μg	L−1	of	18	 D-(+)-camphor-10-sulfonic	acid	as	an	internal	standard	for	semi-quantitative	analysis.	19	 After	centrifugation	at	15,000	× g	at	4	°C	for	5 min,	10	μL	of	the	upper	phase	was	used	for	20	 quantification	of	intracellular	metabolites	by	high-performance	liquid	chromatography	21	 coupled	with	electrospray	ionisation	tandem	mass	spectrometry	(LCMS-8040	triple	22	 quadrupole	LC-MS/MS	spectrometer;	Shimadzu,	Japan)	as	described	previously	[24].	23	 	24	
2.5	GC-MS	analysis	of	metabolites.	For	GC-MS	analysis,	70	μL	of	the	upper	phase,	as	for	25	 LC-MS/MS	analysis,	was	transferred	to	a	new	tube	and	vacuum	dried.	The	dried	residue	26	
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was	derivatised	for	90	min	at	30	°C	in	20	mg	mL-1	methoxyamine	hydrochloride	in	1	 pyridine	(20	μL).	Subsequently,	trimethylsilylation	(TMS	derivatisation)	was	performed	2	 for	30	min	at	37	°C	and	then	for	2	h	at	room	temperature	with	N-methyl-N-3	 (trimethylsilyl)trifluoroacetamide	(MSTFA,	50	μL)	[25,	26].	GC-MS	was	carried	out	using	a	4	 GCMS-QP2010	Ultra	(Shimadzu,	Japan)	equipped	with	a	CP-Sil	8	CB-MS	capillary	column	5	 (30	m	×	0.25	mm	×	0.25	μm;	Agilent,	USA).	Helium	was	used	as	the	carrier	gas	with	a	flow	6	 rate	of	2.1	mL	min-1.	The	injection	volume	was	1	μL	with	a	split	ratio	of	1:10.	An	initial	7	 oven	temperature	of	60°C	was	maintained	for	10	min,	then	raised	to	315	°C	at	15	°C	min-1,	8	 and	maintained	for	6	min.	The	total	running	time	was	33	min.	The	other	settings	were	as	9	 follows:	250	°C	interface	temperature,	200	°C	ion	source	temperature,	and	electron	impact	10	 (EI)	ionisation	at	70	eV.	11	 	12	
2.6	13C	metabolic	flux	analysis.	Cells	were	harvested	in	the	logarithmic	growth	phase	by	13	 centrifugation	and	then	hydrolysed	in	5	M	HCl	at	100	°C	for	20	h.	Amino	acids	were	14	 purified	and	evaporated	as	previously	described	[27],	and	then	derivatised	prior	to	their	15	 analysis	by	GC-MS,	as	previously	described	[28]	The	flux	distribution	ratio	between	16	 glycolysis	and	the	PPP	was	determined	as	previously	described	[29].	Briefly,	almost	all	17	 mass	isotopomer	fractions,	especially	serine,	glycine,	and	alanine,	show	significant	18	 variations	depending	on	the	distribution	ratio.	In	this	study,	[1-13C]	labeled	glucose	was	19	 used	to	analyse	that	ratio.	Lower	proportions	of	the	m1	fractions	of	the	above	amino	acids	20	 are	seen	by	GC-MS	at	higher	PPP	fluxes.	This	is	due	to	the	loss	of	labeled	C1	in	the	21	 decarboxylation	reaction	of	the	oxidative	PPP.	That	is,	labeled	carbon	atoms	can	exit	only	22	 through	glycolysis.	Therefore,	the	split	ratio	of	glycolysis	can	be	determined	by	dividing	23	 the	labeled	mass	fractions	of	serine,	glycine	and	alanine	by	the	unlabeled	fraction.	24	 	25	
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2.7	HPLC	analysis	for	measurement	of	organic	acids	in	medium.	Supernatant	of	the	1	 cell	broth,	recovered	after	centrifugation,	was	used	for	HPLC	using	a	Prominence	HPLC	2	 System	(Shimadzu,	Japan)	with	a	conductivity	detector	and	two	Shim-pack	SCR-102H	3	 columns	(300	mm	x	8.0	mm;	I.D.,	7	μm;	Shimadzu,	Japan).	The	column	temperature	was	48	4	 °C	and	the	flow	rate	of	the	mobile	phase	(5	mM	p-toluenesulfonic	acid;	p-TSA)	was	0.8	mL	5	 min-1.	The	flow	rate	of	the	pH	buffering	solution	for	the	detector	(5	mM	p-TSA,	20	mM	Bis-6	 Tris,	and	0.1	mM	EDTA-4H)	was	0.5	mL	min-1.		7	 	8	
2.8	2d-DIGE	comparison	of	protein	expression.	The	same	20	mL	samples	from	the	9	 fermentation	cultures	as	described	for	the	metabolomics	study	were	used	for	the	10	 proteomic	study.	A	10	mL	aliquot	of	each	sample	was	centrifuged	at	4000	×	g	for	15	min	to	11	 recover	the	cells.	The	pellet	was	then	washed	3	times	by	repeated	suspension	and	12	 centrifugation,	in	an	ice-cold	buffer	consisting	of	10	mM	Tris	(pH	8.0)	and	5	mM	13	 magnesium	acetate.	Washed	pellets	were	stored	at	-80	°C	until	all	samples	had	been	14	 collected,	and	then	prepared	for	analysis	simultaneously.		15	 	16	 Cells	were	resuspended	in	lysis	buffer	(7	M	urea,	2	M	thiourea,	30	mM	Tris	and	4%	(w/v)	17	 CHAPS)	and	lysed	by	sonication	on	ice.	The	sonication	protocol	consisted	of	12	cycles	of	18	 10	sec	with	10	sec	rest	periods	between.	The	pulse	amplitude	was	set	to	15	Amp	resulting	19	 in	a	pulse	power	of	8	–	9	W.	After	complete	lysis,	the	protein	concentration	was	measured	20	 using	a	Bradford	microplate	assay	procedure.	Controls	consisting	of	bovine	serum	21	 albumin	were	prepared	in	the	same	lysis	buffer	to	prepare	a	standard	curve.	The	pH	of	22	 each	sample	was	also	checked	and	found	to	be	close	to	pH	8.5,	which	is	optimal	for	the	23	 labelling	procedure.	24	 	25	
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An	internal	standard	was	created	by	pooling	equal	amounts	of	protein	from	every	sample.	1	 For	the	test	samples,	50	μg	of	protein	was	labelled	for	each	sample.	Labelling	was	carried	2	 out	with	the	CyDye	DIGE	Fluor	minimal	labelling	kit	(GE	Healthcare,	US)	using	Cy2	for	the	3	 internal	standard	and	Cy3	and	Cy5	for	test	samples.	Groups	of	two	test	samples	were	then	4	 combined	together	with	an	internal	standard	sample,	and	mixed	with	an	equal	volume	of	5	 2×	sample	buffer	(7M	urea,	2	M	thiourea,	2%	(w/v)	CHAPS,	0.5%	IPG	buffer	(pH	3	–	11	6	 NL)	and	De-streak	reagent).	Finally,	the	volume	was	made	up	to	450	μL	with	rehydration	7	 solution	(7	M	urea,	2	M	thiourea,	2%	(w/v)	CHAPS).	Each	sample	was	loaded	onto	a	24	cm	8	 Immobiline	DryStrip	(pH	3	–	11	NL)	using	the	rehydration	method,	with	rehydration	9	 proceeding	for	12	h	at	20	°C.	Isoelectric	focusing	then	proceeded	with	an	initial	step	of	500	10	 mV	for	1	h,	followed	by	a	gradient	to	100	mV	over	8	h,	a	gradient	to	8000	mV	over	3	h	and	11	 a	final	step	with	the	voltage	held	at	8000	mV	for	3.75	h.	12	 	13	 The	second-dimension	electrophoresis	was	conducted	using	the	Ettan	DALT	gel	and	14	 electrophoresis	system	(GE	Healthcare,	USA).	24	cm	pre-casted	gels	were	used	following	15	 equilibration	of	the	focused	IEF	strips.	8	gels	were	run	simultaneously	with	12	mA	per	gel,	16	 with	a	recirculating	pump	and	chiller	to	maintain	the	buffer	temperature	at	15	°C,	for	17	h	17	 until	the	bromophenol	blue	dye	front	just	reached	the	end	of	the	gel.	The	gels	were	then	18	 immediately	scanned	using	a	Typhoon	9400	variable	mode	imager	(Amersham	19	 Biosciences,	UK)	and	following	the	manufacturer’s	recommended	settings.	The	images	20	 were	analysed	to	detect	changes	in	protein	concentrations	using	DeCyder	2-D	v.6.5	image	21	 analysis	software.	22	 	23	
2.9	Protein	digestion	and	identification.	A	preparatory	gel	containing	500	μg	of	24	 unlabeled,	pooled	samples	was	run	under	the	same	conditions	as	for	the	analytical	gel,	and	25	 post-stained	using	SYPRO	Ruby	(Fisher	Scientific,	Japan).	Following	spot	matching	in	26	
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DeCyder	2-D,	the	selected	spots	were	excised	using	an	Ettan	spot	picker	(Amersham	1	 Biosciences,	UK).	The	spots	were	de-stained	in	50	mM	ammonium	bicarbonate	containing	2	 50%	acetonitrile	(50	μL)	for	10	min	at	37	°C,	dehydrated	with	acetonitrile	(25	μL)	then	3	 dried	in	a	vacuum	centrifuge.	To	reduce	cysteine	residues,	100	mM	ammonium	4	 bicarbonate	with	10	mM	dithiothreitol	(25	μL)	was	added	for	15	min	at	50	°C,	then	250	5	 mM	iodoacetamide	in	100	mM	ammonium	bicarbonate	(2	μL)	was	then	added	and	the	6	 spots	were	incubated	for	15	min	at	room	temperature	in	the	dark	for	alkylation.	After	7	 washing	and	dehydration	as	before,	the	protein	in	the	dried	gel	debris	was	digested	at	37	8	 °C	overnight	with	100	ng/10	μL	modified	trypsin	solution.	The	digested	protein	fragments	9	 were	collected	from	the	supernatant	and	extracted	from	the	gel	debris	by	the	addition	of	10	 50-80%	acetonitrile	containing	1%	trifluoroacetic	acid	(3	×	25	μL).		11	 	12	 The	resulting	protein	sample	was	resolved	in	2%	acetonitrile	containing	0.1%	13	 trifluoroacetic	acid	and	applied	to	the	liquid	chromatography	(LC)	system	(Advance	14	 nanoLC;	Bruker-Michrom,	USA)	coupled	to	an	LTQ	linear	ion	trap	mass	spectrometer	15	 (ThermoFisher,	USA)	with	a	nanospray	ion	source	in	positive	mode.	The	peptides	were	16	 separated	on	a	NANO-HPLC	C18	capillary	column	(0.075	mm	ID	×	150	mm	length,	3	mm	17	 particle	size;	Nikkyo	Technos,	Japan)	using	a	linear	gradient	(25	min,	5-35%	acetonitrile	18	 containing	0.1%	formic	acid)	at	a	flow	rate	of	300	nL/min.	The	LTQ-MS	was	operated	in	19	 top-3	data-dependent	scan	mode.	The	precursor	ions	were	selected	automatically	for	20	 MS/MS	analysis	on	the	basis	of	their	signal	intensities.	The	parameters	of	LTQ	were	as	21	 follows:	spray	voltage,	2.3	kV;	capillary	temperature,	250	°C;	mass	range	(m/z),	400-1800;	22	 collision	energy,	35%.	Raw	data	was	acquired	by	Xcalibur	software.	The	MS/MS	data	were	23	 searched	against	the	SwissProt	2014_10	database	using	MASCOT	v.2.4.1	software	(Matrix	24	 Science,	UK).	The	MASCOT	search	parameters	were	as	follows:	enzyme,	trypsin;	fixed	25	 modifications,	carbamidomethyl	(Cys);	variable	modifications,	oxidation	(Met);	peptide	26	
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mass	tolerance,	±	1.5	Da;	fragment	mass	tolerance,	±	0.8	Da;	max.	missed	cleavages,	1.	1	 Significant	MASCOT	scores	were	defined	with	p	≤	0.05.	2	 	3	
2.10	Data	analysis	4	 Data	pre-treatment	and	MEBA	were	done	in	Microsoft	Excel	and	using	an	online	user	5	 interface	for	metabolomics	data	analysis	in	R,	MetaboAnalyst	3.0	[30].	Pre-treatment	6	 involved	grouping	all	data	by	growth	condition,	normalising	concentrations	by	the	OD600	7	 at	which	the	sample	was	taken,	then	centering	and	Pareto	scaling	to	generate	relative	8	 concentration	changes.	All	other	statistical	analyses	were	performed	in	R,	and	graphs	9	 were	produced	in	R	and	Origin	8.0	(OriginLab,	USA).	10	 	11	
	12	
3	Results		13	 We	grew	the	wild-type	and	hnsΔ93	mutant	strain	of	E.	coli	W3110	in	3	L	aerobic,	fed-batch	14	 fermentations	with	or	without	the	addition	of	indole.	The	hnsΔ93	cultures	grew	slower	15	 than	the	wild-type	(Fig.	1A).	Therefore,	we	normalised	the	early	culture	conditions	by	16	 inoculating	into	modified	mineral	salts	medium	(M9GYT)	containing	0.4%	glucose,	0.2%	17	 yeast	extract	and	trace	elements,	and	growing	until	the	initial	carbon	supply	was	18	 exhausted.	At	this	stage,	every	culture	reached	the	same	optical	density	at	600	nm	(OD600;	19	 overall	average	6.69,	standard	deviation	0.48).	The	nutrient	feed	was	then	started	and	20	 quiescence	was	induced	30	min	later	by	addition	of	indole	(final	concentration	of	3	mM	21	 from	a	1	M	stock	dissolved	in	ethanol)	or	an	equivalent	volume	of	pure	ethanol.	Only	22	
hnsΔ93	cultures	entered	quiescence,	whereas	wild-type	growth	was	inhibited	but	not	23	 stopped	by	indole.	24	
3.1	Global	protein	expression	changes	are	primarily	due	to	the	hns	mutation	25	
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We	hypothesised	that	the	signaling	and	protonophore	effects	of	indole	would	lead	to	1	 widespread,	significant	changes	in	protein	expression.	However,	since	H-NS	regulates	2	 approximately	5%	of	all	gene	expression	in	E.	coli	[31]	we	expected	that	the	hnsΔ93	3	 mutation	would	also	affect	patterns	of	protein	expression.	To	investigate	these	effects,	we	4	 drew	samples	for	protein	expression	profiling	1	h	after	the	addition	of	indole.	Surprisingly,	5	 2-dimensional	differential	in-gel	electrophoresis	(2d-DIGE)	showed	that	almost	all	the	6	 variation	in	protein	expression	was	due	to	the	strain	genotype	rather	than	indole	addition	7	 (Fig.	1B),	with	distinct	clusters	formed	by	each	strain	(Fig.	1D).	A	total	of	424	protein	spots	8	 were	present	in	every	spot	map	(complete	cases).	Of	the	303	spots	that	showed	significant	9	 (p	≤	0.05)	expression	changes,	237	(78%)	were	due	to	only	the	strain	and	27	(9%)	were	10	 due	to	only	indole	addition	(Fig.	1C).	Using	more	stringent	criteria,	we	identified	43	11	 protein	spots	with	≥	3-fold	increase	or	decrease	in	expression	compared	to	the	control	(p	12	 ≤	0.001).	Analysis	of	variance	(ANOVA)	for	the	43	selected	spots	showed	that	39	spots	13	 varied	due	to	the	strain	and	2	spots	due	to	indole	addition.	The	remaining	2	spots	varied	14	 due	to	a	combination	of	indole	and	strain,	although	there	was	no	interaction.		15	 	16	 The	43	selected	spots	were	excised	from	the	gel,	digested	by	trypsin	and	subjected	to	17	 peptide	fingerprinting	analysis	via	mass	spectrometry.	The	results	were	queried	against	18	 the	SwissProt	database	using	MASCOT	v.2.4.1,	and	we	were	able	to	identify	12	spots	with	a	19	 high	certainty	of	representing	a	single	protein	(or,	in	one	case,	two)	(Table	1).	Of	the	12	20	 proteins	identified,	8	are	regulated	by	H-NS	according	to	the	Ecocyc	database	[32].Of	21	 these,	7	are	involved	in	stress	response	functions	and	were	up-regulated	in	the	hnsΔ93	22	 strain.	This	suggests	Q-cells	might	be	‘primed’	for	metabolic	stresses	induced	by	indole	23	 addition	to	the	medium.	Interestingly,	PyrB	expression	was	reduced	in	hnsΔ93.	We	noted	24	 earlier	that	the	hnsΔ93	mutant	grew	more	slowly	than	the	wild-type	in	mineral	salts	25	 medium.	PyrB	knockout	mutants	are	unable	to	grow	in	M9	medium	due	to	a	reduction	in	26	
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nucleotide	synthesis,	so	the	reduction	in	PyrB	expression	in	the	mutant	might	explain	its	1	 reduced	growth	rate	in	our	experiment	[33].	2	 	3	
3.2	Indole	and	strain	effects	both	contribute	towards	establishment	of	quiescence	4	
We	expected	that	by	modifying	the	PMF	indole	would	have	widespread	knock-on	effects	5	 on	central	carbon	metabolism.	To	investigate	the	extent	of	these	effects	and	identify	6	 pathways	that	could	be	amenable	to	metabolic	engineering,	we	conducted	a	time-course	7	 study	over	240	min	from	the	time	of	indole	addition.	We	tracked	the	intracellular	8	 concentrations	of	22	cofactors	and	intermediates	of	glycolysis	and	PPP	using	liquid	9	 chromatography	–	tandem	mass	spectrometry	(LC–MS/MS),	and	8	organic	acids	10	 (pyruvate,	lactate	and	intermediates	of	TCA)	by	gas	chromatography	–	mass	spectrometry	11	 (GC–MS).	Glucose-ADP,	isocitrate	and	NADH	were	removed	from	the	analysis	due	to	very	12	 low	abundances.	We	also	followed	the	extracellular	concentrations	of	6	organic	acids	by	13	 high	performance	liquid	chromatography	(HPLC).	The	quantitative	(GC–MS	and	HPLC)	14	 and	relative	ratio	(LC–MS/MS)	concentrations	for	the	33	analysed	species	were	15	 normalised	against	the	OD600	of	the	cultures	at	each	time	point.	Results	using	each	16	 technology	were	then	analysed	in	parallel,	since	direct	comparisons	between	the	two	17	 concentration	reporting	modes	were	not	possible.		18	 	19	 Metabolites	tended	to	cluster	with	neighboring	intermediates	of	their	respective	pathways	20	 (Fig.	2B,	C),	showing	that	any	metabolic	changes	tended	to	affect	whole	pathways	more	21	 than	individual	intermediates.	Individual	principal	component	analyses	(PCA)	for	each	22	 time-point	of	the	LC-MS/MS	data	revealed	a	dynamic	interaction	between	the	influences	of	23	 strain	differences	and	indole	(Fig.	2D,	Supplementary	Fig.	1).	Before	indole	addition,	the	24	 samples	were	relatively	closely	clustered	with	some	separation	by	strain	along	principal	25	
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component	(PC)	1	(accounting	for	56%	of	the	observed	difference).	Within	5	min	of	indole	1	 addition,	indole	treatment	became	the	dominant	clustering	factor,	while	PC1	became	less	2	 important	(38.3%	of	observed	differences).	The	influence	of	indole	became	more	3	 pronounced	over	the	following	60	min,	but	by	240	min	the	samples	tended	to	cluster	more	4	 closely	again,	with	some	separation	by	strain.	Untreated	culture	density	was	already	high	5	 by	this	time	and	growth	may	have	begun	to	slow.	This	suggests	that	the	quiescent	6	 metabolic	state	resembles	the	late-logarithmic	or	early	stationary	phase	of	batch	cultures.	7	 The	GC-MS	data	revealed	a	similar	trend	for	organic	acids	(Supplementary	Fig.	2).	8	
	9	
3.3	Indole	causes	re-routing	of	metabolic	flow	and	pooling	of	metabolites	from	10	
glycolysis	in	hnsD93	cells		11	
To	identify	the	metabolites	with	the	most	significant	changes	in	concentration	during	12	 quiescence,	we	compared	the	time-courses	of	each	intracellular	metabolite	between	the	13	 control	(wild-type,	0	mM	indole)	and	quiescent	cultures,	and	ranked	them	by	the	variation	14	 in	time-course	profile	using	Multivariate	Empirical	Bayes	Analysis	for	time-course	data	15	 (MEBA)	[34].	Intermediates	of	PPP	were	unchanged	or	decreased	in	concentration	over	16	 time	under	either	condition	(Table	2).	However,	glycolysis	intermediates	were	present	at	17	 higher	concentrations	in	quiescent	cells	than	in	the	control.	We	noted	particularly	18	 significant	increases	in	metabolites	towards	the	later	stages	of	glycolysis,	namely	19	 phosphoenolpyruvate	(PEP),	3-phosphoglycerate	and	2-PG	(3/2-PG),	and	Ac-CoA,	of	20	 which	the	latter	two	increased	over	time	in	quiescent	cells	but	decreased	in	the	control.		21	 MEBA	also	revealed	an	effect	of	quiescence	on	the	TCA	cycle	(Table	2).	In	control	cultures,	22	 TCA	intermediates	slowly	increased	in	concentration	during	growth.	However,	in	23	 quiescent	cultures	pyruvate	and	acids	from	the	first	half	of	TCA	reduced	in	concentration,	24	 whereas	those	in	the	second	half	increased	above	the	levels	of	the	control.	With	the	25	
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simultaneous	increase	in	Ac-CoA,	this	suggests	indole	inhibits	the	TCA	cycle,	possibly	by	1	 preventing	the	conversion	of	Ac-CoA	to	citrate	and/or	altered	regulation	of	the	control	2	 point	between	PEP	and	pyruvate.		3	 	4	 While	MEBA	only	compared	quiescent	and	control	cultures,	examination	of	the	individual	5	 graphs	of	concentration	versus	time	for	each	metabolite	and	cofactor	under	all	four	6	 growth	conditions	(Supplementary	Fig.	3	–	7)	shows	that	indole	alone	had	substantial	7	 effects	on	certain	metabolite	concentrations.	Wild-type	cells	supplemented	with	indole	8	 rapidly	built	up	large	pools	of	F6P,	G6P	and	Ac-CoA,	exceeding	the	concentrations	in	9	 quiescent	cultures.	However,	the	effect	was	short-lived	and	the	concentrations	rapidly	10	 decreased	again	after	120	min.	In	comparison,	metabolic	changes	during	the	quiescent	11	 state	appear	generally	to	be	more	gradual	and	to	endure	for	longer.		12	 	13	 Supplementary	Fig.	4	shows	that	wild-type	cells	had	greater	starting	concentrations	of	14	 PPP	intermediates	than	hnsD93.	However,	both	strains	had	identical	flux	ratios	through	15	 glycolysis,	PPP	and	the	Entner-Doudoroff	pathway	in	13C-labelled	chemostat	experiments	16	 without	indole	(Supplementary	Table	1).	Due	to	its	effect	on	growth,	we	could	not	17	 investigate	the	changes	in	metabolic	flux	caused	by	indole.	However,	Fig.	2A,	C	and	Table	2	18	 both	suggest	that	indole	causes	a	non-H-NS	dependent	re-routing	of	metabolic	flux	away	19	 from	the	PPP.		20	 	21	 HPLC	measurements	of	the	culture	medium	showed	that	acetate	was	the	predominant	22	 extracellular	carboxylic	acid	in	all	cultures.	Formate	was	also	produced	in	low	23	 concentrations,	but	pyruvate,	lactate,	succinate	and	fumarate	were	only	detected	in	trace	24	 amounts	(Supplementary	Fig.	7).	The	kinetics	of	acetate	production	(Fig.	2B)	suggested	25	 that	in	the	absence	of	indole,	the	acetate	switch	mechanism	[35]	triggered	acetate	26	
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accumulation	as	glucose	became	depleted	at	high	culture	densities.	In	the	presence	of	1	 indole,	acetate	was	produced	continually	throughout	the	culture,	reaching	particularly	2	 high	specific	concentrations	in	quiescent	cells.	Thus,	acetate	production	may	have	acted	as	3	 an	outlet	for	the	glycolysis	intermediates	that	accumulated	due	to	the	disruption	of	the	4	 TCA	cycle.		5	 	6	 A	key	function	of	the	TCA	cycle	is	to	reduce	NAD+	to	NADH,	which	acts	as	an	electron	7	 donor	for	the	electron	transport	chain.	In	our	experiment,	the	concentrations	of	NAD+	and	8	 the	related	molecule	NADP+	slowly	decreased	over	4	h	under	all	conditions,	but	remained	9	 highest	for	hnsΔ93	with	3	mM	indole	(Supplementary	Fig.	6).	The	concentrations	of	the	10	 reduced	forms	of	both	molecules	were	also	lower	than	the	oxidised	forms;	in	the	case	of	11	 NADH,	below	the	limit	of	detection.	Furthermore,	concentrations	of	adenosine	phosphates	12	 remained	more	constant	in	quiescent	cultures	than	under	other	conditions.	This	supports	13	 the	suggestion	from	the	proteomics	study	that	Q-cells	are	‘primed’	for	the	metabolic	14	 stresses	caused	by	indole,	and	so	can	maintain	their	redox	balance	even	while	15	 experiencing	shifts	in	metabolite	concentrations.	16	 	17	
3.4	Application	of	Q-cells	to	the	production	of	3-hydroxybutyrate	18	
Our	metabolomics	analysis	identified	the	potential	for	Q-cells	to	become	efficient	primary	19	 metabolite	cell	factories	through	targeted	metabolic	engineering	using	PEP	or	Ac-CoA	as	20	 starting	points.	To	test	this	principle,	we	chose	3HB	as	a	model	for	metabolite	production	21	 as	it	requires	the	expression	of	only	three	heterologous	enzymes	for	its	production	from	22	 Ac-CoA	and	its	presence	in	the	growth	medium	can	be	assayed	simply	with	commercially-23	 available	kits.	To	produce	3HB,	two	molecules	of	Ac-CoA	are	condensed	by	a	β-24	 ketothiolase	(PhaA	from	Cupriavidus	necator)	and	reduced	at	the	β-position	by	an	25	
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acetoacetyl-CoA	reductase	(PhaB	from	C.	necator),	before	the	CoA	moiety	is	removed	by	an	1	 overexpressed	E.	coli	thioesterase	B	(TesB)	[36,	37],	as	illustrated	in	Supplementary	Fig.	8.		2	 	3	 We	introduced	plasmid	pTrctesBphaAB	into	E.	coli	W3110hnsΔ93	to	enable	it	to	produce	4	 3-hydroxybutyrate	(3HB)	in	an	IPTG-inducible	manner.	Terrific	broth	(TB)	with	glucose	as	5	 the	carbon	source	was	chosen	as	the	culture	medium	to	avoid	the	slow	growth	of	the	6	
hnsΔ93	strain	in	M9GYT	(Fig.	1A)	[38].	Pilot	experiments	demonstrated	that	quiescence	7	 could	be	achieved	with	2.5	mM	indole	so	we	used	this	concentration	to	minimise	the	8	 potential	for	indole	toxicity.	After	26	h	the	quiescent	culture	reached	an	OD600	of	34.0,	9	 compared	to	63.7	for	a	control	culture	with	ethanol	added	in	place	of	the	indole	solution	10	 (Fig.	4A).	This	corresponded	to	dry	cell	weights	(DCW)	of	13.3	g	L-1	and	24.8	g	L-1	11	 respectively.	Growth	of	the	cultures	was	almost	identical	until	indole	addition,	after	which	12	 the	Q-cell	culture	gradually	ceased	growing.	Despite	the	reduced	cell	density,	the	3HB	13	 concentration	in	the	Q-cell	culture	reached	374.8	mM	(39.4	g	L-1)	at	26	h	compared	to	14	 178.4	mM	(18.6	g	L-1)	for	the	control	(Fig.	4B).	Therefore,	over	the	26	h	duration	of	the	15	 experiment,	the	specific	productivity	of	the	quiescent	culture	was	4.0-fold	greater	than	for	16	 the	control	(0.114	against	0.029	gproduct	gcells-1	h-1),	while	the	absolute	concentration	in	the	17	 culture	supernatant	was	2.1-fold	greater.	18	 	19	 Importantly,	the	rates	of	substrate	(glucose,	S)	utilisation	(dS/dt)	were	very	similar	for	20	 both	cultures	at	all	stages	of	the	fermentation	(Fig.	4C).	On	the	other	hand,	the	specific	21	 product	(3HB,	P)	formation	rates	(given	by	1/X(dP/dt),	where	X	is	biomass),	representing	22	 the	amount	of	3HB	produced	per	unit	of	time	per	unit	of	biomass,	were	initially	similar	but	23	 diverged	9	h	into	the	experiment	(Fig.	4D).	Comparison	with	Fig.	4A	demonstrates	that	the	24	 divergence	corresponds	with	entry	of	the	control	culture	into	stationary	phase.	The	abrupt	25	 halt	in	cell	growth	for	the	control	culture	was	likely	due	to	a	combination	of	high	cell	26	
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density	and	product	inhibition	caused	by	3HB.	Q-cells	may	be	more	tolerant	of	high	3HB	1	 concentrations	due	to	not	having	a	requirement	for	growth	and	division.	3HB	production	2	 is	linked	to	the	metabolic	rate	of	the	cell.	Therefore,	the	control	culture	became	3	 unproductive	as	metabolism	slowed	upon	entry	into	stationary	phase,	whereas	the	4	 quiescent	culture	continued	to	produce	3HB.	It	is	this	extended	production	period	that	5	 accounts	for	the	superior	productivity	of	quiescent	cultures.	Ceasing	growth	clearly	allows	6	 quiescent	cultures	to	take	advantage	of	the	large	pool	of	available	metabolites	that	were	7	 revealed	by	our	metabolomics	analysis.	8	
	9	
4	Discussion		10	 We	show	here	that	the	hnsΔ93	mutation	leads	to	wide-scale	changes	in	protein	expression	11	 and	metabolite	balance.	Most	significantly,	stress	response	genes	were	upregulated,	in	12	 agreement	with	previous	characterisation	of	protein	expression	changes	in	an	hns	13	 knockout	strain	[39].	Our	results	suggest	that	the	hnsΔ93	mutation	essentially	‘primes’	14	 cells	for	the	effect	of	indole	on	metabolism	and	prepares	the	cells	for	quiescence.	When	15	 indole	is	present,	metabolism	proceeds	in	a	redox-imbalanced	fashion,	resulting	in	16	 decreased	NAD+	and	NADP+	concentrations	as	the	pathways	that	regenerate	them	are	17	 inhibited	(Fig.	3).	In	the	wild-type	strain	this	soon	leads	to	oxidative	damage	by	reactive	18	 oxygen	species	(ROS)	[40,	41].	However,	in	hnsΔ93,	elevated	concentrations	of	stress-19	 response	proteins	may	enable	the	ROS	to	be	neutralised,	partly	by	oxidising	NADH	and	20	 NADPH.	Therefore,	the	increased	defense	against	oxidative	stress	in	Q-cells	may	also	act	to	21	 regenerate	cofactors,	allowing	for	continued	glucose	metabolism.	This	model	of	indole	22	 action	could	shed	further	light	on	the	metabolic	shift	that	takes	place	as	wild-type	cells	23	 transition	from	exponential	to	stationary	phase	[42].	For	example,	it	might	be	of	benefit	24	 for	cells	to	repress	the	TCA	cycle	when	less	energy	is	required	to	power	cell	growth	and	25	
	 22 
division,	and	divert	metabolic	energy	towards	cell	maintenance	pathways	leading	from	the	1	 PPP	and	glycolysis.		2	 	3	 A	comprehensive	survey	of	protein	expression	changes	due	to	indole	has	not	been	carried	4	 out	in	E.	coli,	but	it	has	been	suggested	that	proteins	involved	in	drug	and	acid	resistance	5	 [43–45],	biofilm	formation	[46–48],	amino	acid	metabolism	[49],	virulence	[50],	and	even	6	 inter-species	communication	[17,	51]	are	all	affected	by	indole.	A	microarray	study	of	7	 indole-induced	expression	changes	in	Salmonella	found	only	77	differentially	expressed	8	 proteins	[52].	Although	we	imposed	more	stringent	cut-off	parameters	for	the	selection	of	9	 significant	expression	changes,	our	results	are	in	agreement	that	indole	does	not	affect	the	10	 expression	of	a	large	number	of	genes.	11	 	12	 DNA	replication	and	gene	transcription	in	E.	coli	are	coordinated	throughout	the	growth	13	 cycle	by	controlling	the	topological	structure	of	the	chromosome	[53–55].	It	has	also	been	14	 suggested	that	a	high	density	of	DNA	gyrase	binding	sites	(and	consequently	high	15	 superhelical	density)	near	to	the	replication	origin	is	correlated	with	genes	that	are	16	 expressed	early	in	the	growth	cycle	[56,	57].	Indole	inhibits	DNA	gyrase,	but	is	not	thought	17	 to	have	a	strong	effect	at	3	mM	[58].	Therefore,	the	protein	expression	and	metabolic	18	 effects	we	observed	are	unlikely	to	be	a	consequence	of	DNA	gyrase	inhibition	by	indole.	19	 As	noted	before,	other	mutations	in	hns	do	not	allow	the	induction	of	quiescence	[14].	20	 Therefore,	we	conclude	that	the	hnsΔ93	mutation	affects	the	binding	of	H-NS	to	DNA	in	a	21	 way	that	loosens	its	control	over	the	expression	of	a	subset	of	the	genes	which	it	inhibits,	22	 and	that	this	subset	includes	a	large	number	of	stress	response	genes.	23	 	24	 It	is	not	necessary	for	indole	to	affect	protein	expression	in	order	to	influence	metabolite	25	 concentrations	since	metabolic	balance	is	controlled	largely	through	modulation	of	26	
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enzyme	activity	[59].	Similarly,	it	is	to	be	expected	that	the	concentration	changes	we	1	 observed	were	relatively	modest	as	E.	coli	is	well	evolved	to	maintain	its	metabolic	2	 balance	under	a	wide	variety	of	stressful	conditions.	Indeed,	many	metabolic	engineering	3	 strategies	fail	due	to	the	flexible	E.	coli	metabolism	finding	‘work-arounds’	through	the	4	 expression	of	isozymes	and	the	existence	of	alternative	metabolic	pathways	[60].	While	5	 the	most	significant	changes	in	this	study	were	in	the	region	between	glycolysis	and	the	6	 TCA	cycle,	the	data	also	indicate	a	general	rapid	decrease	in	PPP	intermediates.	The	effect	7	 appears	to	be	independent	of	the	hnsD93	mutation	and	may	be	due	to	an	indole-mediated	8	 re-routing	of	metabolic	flux	away	from	the	PPP.	One	might	also	expect	that	in	the	9	 quiescent	state,	secondary	pathways	such	as	for	amino	acid,	lipid	and	nucleic	acid	10	 metabolism	would	also	experience	decreased	flux	due	to	lower	demands	from	biomass	11	 production.	However,	further	studies	are	required	to	confirm	and	characterise	this	12	 inference.		13	 	14	 As	a	protonophore,	indole	reduces	the	PMF,	leading	to	increased	proton	pumping	by	the	15	 electron	transfer	chain	[61].	This	stimulates	demand	for	NADH	from	the	TCA	cycle,	leading	16	 to	an	increased	rate	of	respiration.	However,	in	our	experiments	the	TCA	cycle	was	17	 disrupted	by	indole.	Continued	supply	of	glucose	into	glycolysis	but	reduced	activity	in	the	18	 TCA	cycle	led	to	the	build-up	of	glycolytic	intermediates,	particularly	at	the	junction	19	 between	glycolysis	and	the	TCA	cycle.	It	was	recently	reported	that	indole	can	increase	20	 anaerobic	production	of	hydrogen	and	ethanol	in	a	non-hns-mutant	derivative	of	E.	coli	21	 W3110	[62].	This	intriguing	result	suggests	that	the	accumulation	of	glycolysis	products	is	22	 also	seen	in	anaerobic	cultures	exposed	to	indole.	It	would	be	interesting	to	compare	the	23	 same	strain	under	both	aerobic	and	anaerobic	conditions	to	compare	the	effects	of	indole	24	 and	the	strategies	used	by	the	cell	to	maintain	redox	balance.	25	 	26	
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As	an	example	of	the	productive	capacity	of	the	Q-cell	system	we	demonstrated	enhanced	1	 production	of	3HB.	Other	than	adjusting	the	indole	concentration,	we	made	no	attempt	to	2	 optimise	the	production	conditions.	However,	the	39.4	g	L-1	of	3HB	produced	here	was	still	3	 greater	than	the	highest	previously	reported	concentration	of	3HB	of	12.2	g	L-1	from	16.7	g	4	 L-1	DCW	[36].	While	indole	induced	a	temporary	‘burst’	of	Ac-CoA	accumulation	in	wild-5	 type	cultures,	only	the	maintenance	of	a	(still	increased,	albeit	smaller)	pool	of	Ac-CoA	6	 seen	in	quiescent	cultures	could	lead	to	the	longer	productive	period	and	enhanced	7	 production	seen	here.		8	 	9	 By	better	understanding	the	mechanism	of	entry	into	quiescence	we	have	been	able	to	10	 identify	promising	starting	points	for	metabolic	engineering	to	improve	the	hnsΔ93	strain	11	 for	the	production	of	commercially	significant	products	through	exploitation	of	the	12	 accumulated	glycolysis	intermediates.	The	uncoupling	of	production	from	biomass	13	 generation	clearly	leads	to	large	increases	in	efficiency.	Therefore,	we	believe	that	with	14	 additional	metabolic	engineering	and	optimisation	of	growth	conditions,	the	Q-cell	system	15	 will	become	a	powerful	and	flexible	tool	for	industrial-scale	production	of	a	variety	of	high	16	 value	chemicals.	17	 	18	 	 	19	
	 25 
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Table	1.	Identities	and	properties	of	proteins	with	greater	than	3-fold	change	in	1	
concentration	from	the	control	and	p	<	0.001.	Proteins	extracted	from	cells	gown	2	
under	all	four	conditions	were	separated	on	a	series	of	2d-DIGE	gels	as	described	in	3	
the	text.	Significant	differences	in	expression	were	identified	using	DeCyder	2-D	4	
software,	and	the	relevant	spots	were	excised,	digested	and	identified	by	LC-MS/MS.	5	
Spot	
IDa	
Protein	Name	 Gene	 Theoretic
al	Mr	
Fold	
Change̠
b	
Change	
due	to:	
Pathway	/	
function	877	 NADP+-specific	glutamate	dehydrogenase	 gdhA	 48,778	 -4.14	 Strain	 Glutamate	synthesis	1319	 Aspartate	carbamoyltransferase	 pyrB	 34,463	 -6.23	 Strain	 Pyrimidine	nucleotide	synthesis	1932	 Protein	YciF	 yciF	 18,643	 14.90	 Strain	 Osmotic	shock	1988	 Aspartate	carbamoyltransferase	regulatory	chain	 pyrI	 17,338	 -4.59	 Strain	 Regulatory	partner	of	PyrB	2090	 Protein	YciE	 yciE	 19,007	 14.67	 Strain	 Osmotic	shock	2050	 DNA	protection	during	starvation	protein	 dps	 18,684	 5.82	 Strain	 DNA	protection	2121	 50S	ribosomal	protein	L10	 rlpJ	 17,757	 6.94	 Strain	 Ribosome	component	2145	 Uncharacterised	protein	YgaU	 ygaU	 16,053	 3.68	 Strain	 Osmotic	shock	2153	 Peroxiredoxin	 osmC	 15,193	 4.70	 Strain	 Oxidative	stress	2235	 1)	50S	Ribosomal	protein	L9	2)	Outer	membrane	assembly	factor	
1)	rplI		2)	
bamE	
1)	12,149		2)	12,408	 3.40	 Indole	 1)	Ribosome	component	2)	Unknown	2314	 Thioredoxin-1	 trxA	 11,913	 3.25	 Strain	 Control	of	redox	potential	2375	 Protein	YjbJ	 yjbJ	 8,320	 8.90	 Strain	 Osmotic	shock	a	Underlined	ID	numbers	indicate	proteins	regulated	by	H-NS	6	 b	Average	fold	change	in	expression	level	(n	=	4)	1	h	into	the	time-course	experiment.	7	 Positive	numbers	represent	increased	concentration	and	negative	numbers	represent	a	8	 decrease.	9	
	 	10	
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Table	2.	Most	significantly	changed	metabolites	during	the	time-course	experiment.	1	
Metabolites	were	extracted	and	quantified	by	LC-MS/MS	or	GC/MS	as	described	in	2	
the	text.	Significant	differences	in	time-course	concentration	profiles	were	detected	3	
using	the	MEBA	module	in	MetaboAnalyst	3.0	[27].	4	
Metabolite	 Pathway	
Fold	change	
in	WT,	0	mM	
Fold	change	
in	hnsΔ93,	3	
mM	
Hotelling	
T2	
LC-MS/MS	 	 	 	 	Phosphoenolpyruvate	 Glycolysis	 1.13	 2.91	 87.62	Sedoheptulose-7-P	 PPP	 -1.03	 -1.23	 58.72	NAD+	 Cofactor	 -1.48	 -1.28	 53.53	Fructose-1,6-BP	 Glycolysis	 -1.65	 -1.30	 50.44	3/2-phosphoglycerate	 Glycolysis	 -1.01	 1.53	 48.97	ADP	 Cofactor	 -1.28	 1.09	 48.66	Acetyl-CoA	 Glycolysis/TCA	 -1.27	 1.41	 42.27	
	 	 	 	 	Ribose-5-P	 PPP	 -2.56	 -1.38	 35.69	Xylulose-5-P	 PPP	 -1.76	 -1.70	 34.58	Ribulose-5-P	 PPP	 -1.35	 -1.76	 33.05	
	 	 	 	 	
GC-MS	 	 	 	 	α-ketoglutarate	 TCA	 -1.13	 -1.52	 95.42	Malate	 TCA	 1.03	 2.00	 73.18	Succinate	 TCA	 1.72	 2.06	 72.79	Fumarate	 TCA	 1.16	 1.74	 70.56	Citrate	 TCA	 1.23	 -2.81	 64.18	Pyruvate	 Glycolysis/TCA	 1.64	 -1.63	 49.01	Lactate	 Other	 1.57	 -1.51	 42.51		5	6	
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Figure	legends	1	
Figure	1.	Global	changes	in	protein	expression	in	quiescent	cultures.	a,	Growth	2	 curves	of	each	strain	during	the	time-course	experiment.	The	inset	graph	shows	a	3	 magnified	area	of	the	same	data	from	the	time	feeding	was	started	until	30	mins	into	the	4	 time-course.	Error	bars	represent	the	standard	deviations	(n	=	4).	b,	Principal	component	5	 analysis	on	the	protein	expression	data	confirms	a	single	principal	component	accounted	6	 for	the	majority	of	variation,	with	clear	separation	by	strain.	c,	Significantly	up-	and	down-7	 regulated	proteins	from	the	complete	cases,	grouped	by	the	cause(s)	of	the	change	in	8	 expression,	as	determined	by	ANOVA	(p	<	0.05).	d,	Heat	map	of	fold-changes	in	protein	9	 expression	determined	by	2d-DIGE	for	424	complete	cases.		10	 	11	
Figure	2.	Changes	in	metabolite	concentration	during	the	time-course.	a,	Heat	map	of	12	 concentration	changes	in	cofactors	and	intermediates	of	glycolysis	and	PPP	analysed	by	13	 LC-MS/MS.	b,	Heat	map	of	concentration	changes	in	intermediates	of	the	TCA	cycle	plus	14	 pyruvate	and	lactate,	analysed	by	GC-MS.	c,	Accumulation	of	acetate	in	the	culture	medium	15	 for	each	condition	tested.		Error	bars	represent	standard	error	(n	=	4).	Abbreviations	for	16	 metabolite	names:	S7P,	sedoheptulose-7-phosphate;	Ribu5P,	ribulose-5-phosphate;	Rib5P,	17	 ribose-5-phosphate;	X5P,	xylulose-5-phosphate;	G3P,	glyceraldehyde-3-phosphate;	AMP,	18	 adenosine	monophosphate;	DHAP,	dihydroxyacetone	phosphate;	FBP,	fructose-1,6-19	 bisphosphate;	3/2PG,	3-phosphoglycerate	&	2-phosphoglycerate;	PEP,	20	 phosphoenolpyruvate;	ADP,	adenosine	diphosphate;	6PG,	6-phosphogluconate;	ATP,	21	 adenosine	triphosphate;	G6P,	glucose-6-phosphate;	F6P,	fructose-6-phosphate;	Ac-CoA,	22	 acetyl-Coenzyme	A;	GP,	glucose-1-phosphate;	NAD+,	oxidised	nicotinamide	adenine	23	 dinucleotide	(NAD);	NADH,	reduced	NAD;	NADP+,	oxidised	NAD	phosphate	(NADP);	24	 NADPH,	reduced	NADP;	Succ.,	succinate;	Fum.,	fumarate;	Mal.,	malate;	AKG,	α-25	 ketoglutarate;	Cit.,	citrate;	Pyr.,	pyruvate;	Lac.,	lactate.	26	
	27	
Figure	3.	Individual	principal	component	analyses	of	four	time	points	for	the	28	
metabolites	analysed	by	LC-MS/MS.	These	time-points	were	chosen	to	demonstrate	the	29	 rapid	(<	5	min)	but	reversible	(<	240	min)	response	to	indole	addition,	which	outweighed	30	 the	differences	between	the	wild-type	and	hnsΔ93	strains.	Points	represent	individual	31	 fermentations	(n	=	4)	and	ellipses	represent	95%	confidence	intervals.	The	full	series	of	32	 PCA	analyses	for	LC-MS/MS	and	GC-MS	data	are	shown	in	Supplementary	Fig.	1	and	2.	33	
	34	
Figure	4.	Overview	of	changes	in	central	carbon	metabolism	in	quiescent	E.	coli	at	35	
240	min.	The	color	of	each	metabolite	name	corresponds	to	the	average	mean-centered	36	 fold	change	in	concentration	(n	=	4)	at	the	end	of	the	time-course	experiment	for	37	 quiescent	cultures	(hnsΔ93	with	3	mM	indole).	Metabolites	in	grey,	underlined	text	had	38	 concentrations	below	the	limit	of	detection.	Those	in	black	text	were	not	possible	to	detect	39	 with	our	system.	40	
	41	
Figure	5.	Production	summary	of	fed-batch	cultures	of	E.	coli	W3110hnsΔ93	42	
producing	3HB,	with	or	without	the	addition	of	indole	(2.5	mM).	As	cells	enter	43	 quiescence	their	metabolic	effort	is	diverted	away	from	biomass	production	and	can	be	44	 harnessed	for	the	production	of	3HB	by	metabolic	pathway	engineering.	We	show	here	the	45	 results	of	the	experiment	in	which	2.5	mM	indole	was	used.	Similar	results	were	achieved	46	 with	other	indole	concentrations	but	are	not	directly	comparable.	a,	Indole	addition	47	
	 31 
(arrows)	caused	the	culture	to	become	quiescent	within	2	h.	b,	Cumulative	3HB	1	 production	following	induction	with	IPTG	(arrow	heads).	While	the	quiescent	culture	2	 remained	productive,	the	control	stopped	producing	3HB	upon	entry	into	stationary	3	 phase.	c,	Glucose	utilisation	rates	were	the	same	for	both	strains	throughout	the	4	 experiment.	d,	Specific	3HB	formation	rates	(qp)	were	initially	the	same,	but	reduced	in	5	 the	control	during	stationary	phase.	6	 	 	7	
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Figure	1	1	
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Figure	3	1	
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Figure	4	1	
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Figure	5	1	
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